Haemodynamic effects of losartan an angiotensin II receptor antagonist in patients with cirrhosis and portal hypertension.

被引：0
|
作者：
Tripathi, D [1 ]
Therapondos, G [1 ]
Lui, HF [1 ]
Hayes, PC [1 ]
机构：
[1] Royal Edinburgh Infirm, Liver Unit, Edinburgh, Midlothian, Scotland
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1470
引用
收藏
页码：527A / 527A
页数：1
相关论文
共 50 条
  • [31] Efficacy of Irbesartan, an angiotensin II receptor selective antagonist, in the treatment of portal hypertension
    Debernardi-Venon, W
    Barletti, C
    Marzano, A
    Alessandria, C
    Todros, L
    Saracco, G
    Repici, A
    Rocca, G
    Rizzetto, M
    HEPATOLOGY, 1999, 30 (04) : 219A - 219A
  • [32] A 1166C angiotensin II type I receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension
    Sookoian, S
    Castaño, G
    García, SI
    Viudez, P
    González, C
    Pirola, CJ
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (03): : 636 - 642
  • [33] Valsartan, a new angiotensin II antagonist: Tolerability and effects on renal function in patients with renovascular arterial hypertension.
    Arzilli, F
    Favilla, S
    Motolese, M
    Peruzzi, E
    OddouStock, P
    Salvetti, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1582 - A1582
  • [34] New angiotensin II type 1 receptor blocker olmesartan improves portal hypertension in patients with cirrhosis
    Hidaka, Hisashi
    Kokubu, Shigehiro
    Nakazawa, Takahide
    Okuwaki, Yuusuke
    Ono, Kouji
    Watanabe, Masaaki
    Shibuya, Akitaka
    Saigenji, Katsunori
    HEPATOLOGY RESEARCH, 2007, 37 (12) : 1011 - 1017
  • [35] HEMODYNAMIC AND HUMORAL EFFECTS OF THE ANGIOTENSIN-II ANTAGONIST LOSARTAN IN ESSENTIAL-HYPERTENSION
    GROSSMAN, E
    PELEG, E
    CARROLL, J
    SHAMISS, A
    ROSENTHAL, T
    AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (12) : 1041 - 1044
  • [36] HYPOTENSIVE EFFECT OF LOSARTAN, A NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN ESSENTIAL-HYPERTENSION
    TSUNODA, K
    ABE, K
    HAGINO, T
    OMATA, K
    MISAWA, S
    IMAI, Y
    YOSHINAGA, K
    AMERICAN JOURNAL OF HYPERTENSION, 1993, 6 (01) : 28 - 32
  • [37] Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension
    Tikkanen, I
    Omvik, P
    Jensen, HA
    JOURNAL OF HYPERTENSION, 1995, 13 (11) : 1343 - 1351
  • [38] The effect of losartan, an angiotensin II receptor antagonist, on systemic and renal hemodynamics and sodium homeostasis in cirrhosis.
    Girgrah, N
    Liu, P
    Blendis, L
    Wong, F
    HEPATOLOGY, 1997, 26 (04) : 629 - 629
  • [39] Portal hypertension. Not always due to cirrhosis
    Lee, CY
    Harrison, SA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S207 - S207
  • [40] DISCOVERY OF LOSARTAN, THE FIRST ANGIOTENSIN-II RECEPTOR ANTAGONIST
    TIMMERMANS, PBMWM
    DUNCIA, JV
    CARINI, DJ
    CHIU, AT
    WONG, PC
    WEXLER, RR
    SMITH, RD
    JOURNAL OF HUMAN HYPERTENSION, 1995, 9 : S3 - S18
12345